Skip to content

Investigator

Nicolaos Joseph Christodoulides

ORALIVA, INC. · funded by NCI, NIDCR

Companies
2

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$2.3M

Summed across those awards.

First award
Apr 15, 2025

Latest Sep 1, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R41

    Point of care diagnostic to improve access to gynecological screening in low-resource settings

    $400k

    Sep 1, 2025NCIORALIVA, INC.NIH RePORTER · 11186207 (opens the source filing in a new tab)

  2. R44

    AI-linked cytomics-on-a-chip to enable near-real time identification and management of oral lichenoid lesions in primary care

    $1.2M

    Apr 15, 2025NIDCRORALIVA, INC.NIH RePORTER · 10921587 (opens the source filing in a new tab)

  3. R44

    AI-linked cytomics-on-a-chip to enable near-real time identification and management of oral lichenoid lesions in primary care

    $697k

    Apr 15, 2025NIDCRORALIVA, INC.NIH RePORTER · 11321546 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources